BR112022003715A2 - Método, composição e kit para enriquecimento seletivo de tamanho de ácidos nucleicos - Google Patents

Método, composição e kit para enriquecimento seletivo de tamanho de ácidos nucleicos

Info

Publication number
BR112022003715A2
BR112022003715A2 BR112022003715A BR112022003715A BR112022003715A2 BR 112022003715 A2 BR112022003715 A2 BR 112022003715A2 BR 112022003715 A BR112022003715 A BR 112022003715A BR 112022003715 A BR112022003715 A BR 112022003715A BR 112022003715 A2 BR112022003715 A2 BR 112022003715A2
Authority
BR
Brazil
Prior art keywords
phase solution
nucleic acids
kit
composition
phase
Prior art date
Application number
BR112022003715A
Other languages
English (en)
Inventor
To Chiu Yin
Robert Marshak Daniel
Madan Kittur Harsha
Kobayashi Masae
Original Assignee
Phase Scient International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phase Scient International Ltd filed Critical Phase Scient International Ltd
Publication of BR112022003715A2 publication Critical patent/BR112022003715A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

MÉTODO, COMPOSIÇÃO E KIT PARA ENRIQUECIMENTO SELETIVO DE TAMANHO DE ÁCIDOS NUCLEICOS. É fornecido um método para isolar e concentrar ácidos nucleicos de tamanhos alvo selecionados (por exemplo, em incrementos inferiores a 1000 pares de bases) a partir de uma mistura de fluido biológico que compreende combinar a mistura de fluido biológico e um primeiro sistema bifásico aquoso (ATPS) formado a partir de um componente de polímero ou tensoativo de formação de primeira fase dissolvido em uma solução de primeira fase e uma solução de segunda fase, de modo que fragmentos de ácido nucleico alvo abaixo de um tamanho alvo desejado sejam divididos para a dita solução de segunda fase e contaminantes se dividam para a solução de primeira fase, extrair e misturar a solução de segunda fase com um segundo ATPS formado a partir de um componente de polímero ou tensoativo de formação de segunda fase dissolvido em uma solução de terceira fase e uma solução de quarta fase, de modo que os fragmentos de ácido nucleico alvo se dividam e se concentrem na solução de terceira fase, e recuperar os fragmentos de ácido nucleico alvo concentrados da solução de terceira fase. São fornecidos, também, uma composição e kit para isolar e concentrar ácidos nucleicos de tamanhos alvo selecionados, conforme descrito acima.
BR112022003715A 2019-08-27 2020-08-26 Método, composição e kit para enriquecimento seletivo de tamanho de ácidos nucleicos BR112022003715A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962892041P 2019-08-27 2019-08-27
PCT/CN2020/111449 WO2021037075A1 (en) 2019-08-27 2020-08-26 Method, composition and kit for size selective enrichment of nucleic acids

Publications (1)

Publication Number Publication Date
BR112022003715A2 true BR112022003715A2 (pt) 2022-10-25

Family

ID=74683441

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022003715A BR112022003715A2 (pt) 2019-08-27 2020-08-26 Método, composição e kit para enriquecimento seletivo de tamanho de ácidos nucleicos

Country Status (9)

Country Link
US (1) US20220228137A1 (pt)
EP (1) EP4022081A4 (pt)
JP (1) JP2022551032A (pt)
KR (1) KR20220050140A (pt)
CN (1) CN114269943A (pt)
AU (1) AU2020338787A1 (pt)
BR (1) BR112022003715A2 (pt)
CA (1) CA3150638A1 (pt)
WO (1) WO2021037075A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240141316A1 (en) * 2022-11-02 2024-05-02 Phase Scientific International, Ltd. Methods and kits for isolating target nucleic acids below a target size from a sample
WO2024093522A1 (en) * 2022-11-02 2024-05-10 Phase Scientific International, Ltd. Methods, compositions and kits for concentrating target analytes from a bulk fluid sample
US20240141409A1 (en) * 2022-11-02 2024-05-02 Phase Scientific International, Ltd. Methods for isolating target analytes from biological samples using atps and solid phase media

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106662582B (zh) * 2014-03-07 2019-12-10 加利福尼亚大学董事会 用于整合分析物提取、浓缩和检测的装置
TW201840854A (zh) * 2017-03-28 2018-11-16 彥燾 招 準確診斷牙科疾病的方法與設備
JP7323532B2 (ja) * 2017-09-18 2023-08-08 フェーズ サイエンティフィック インターナショナル リミテッド 短い核酸断片の単離、精製及び/又は濃縮のために水性二相系を使用する方法
CN111867721A (zh) * 2018-01-19 2020-10-30 相达生物科技国际有限公司 使用固-液相系统分离和纯化核酸的方法
US11332796B2 (en) * 2018-01-19 2022-05-17 Phase Scientific International, Ltd. Composition and method for concentration and enrichment of nucleic acids
CN110003323B (zh) * 2019-04-02 2021-01-01 武汉大学 一种双水相体系分离纯化蛋白质的方法

Also Published As

Publication number Publication date
US20220228137A1 (en) 2022-07-21
JP2022551032A (ja) 2022-12-07
EP4022081A4 (en) 2023-08-23
KR20220050140A (ko) 2022-04-22
AU2020338787A1 (en) 2022-03-03
CN114269943A (zh) 2022-04-01
WO2021037075A1 (en) 2021-03-04
EP4022081A1 (en) 2022-07-06
CA3150638A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
BR112022003715A2 (pt) Método, composição e kit para enriquecimento seletivo de tamanho de ácidos nucleicos
Garcia et al. Fractionation of proteins and carbohydrates from crude microalgae extracts using an ionic liquid based-aqueous two phase system
BRPI0609278B8 (pt) método para preparar uma composição farmacêutica e composição farmacêutica
DE102008023297B4 (de) Verfahren zur Anreicherung und Isolierung von Nukleinsäuren oder Viren
BR112015012854A2 (pt) método para purificar proteínas terapêuticas
BR112017000805A2 (pt) método para extração de proteínas solúveis de biomassa de microalgas
BR112014016193A2 (pt) método e dispositivo para dissilução rápida
EA201990900A1 (ru) Стабильный при комнатной температуре лиофилизированный белок
BR112015008268A2 (pt) composição de material, kit, dispositivo, cartucho e métodos para a amplificação de ácidos nucleicos
BR112018067597A2 (pt) célula progenitora de fígado adulto, população celular, material biológico, composição, método para avaliar a eficácia, o metabolismo, a estabilidade e/ou a toxicidade de um ou mais compostos, uso da célula ou população celular e kit
CN102823579A (zh) 一种血液保护剂及其制备方法与应用
BR112018005810A2 (pt) método de produção de lignina purificada, lignina purificada, composição de resina e corpo moldeado
RU2017130717A (ru) Кислотная композиция на основе леонардита и аминокислот
BR112017019627A2 (pt) métodos de preparação de polinucleotídeos utilizando composições de sal de cátion multivalente
Osloob et al. Experimental study of choline chloride and K2HPO4 aqueous two-phase system, and its application in the partitioning of penicillin G
BRPI0413031A (pt) processo para lixiviação de metal/extração por solvente
BR112018016394A2 (pt) dispositivo e processo para isolar de ácidos nucleicos de sangue total
BR112014009923A2 (pt) método para preparação de solução de fibrinogênio altamente concentrada e método para preparação de selante de fibrina utilizando o mesmo
CN106008705A (zh) 一种双水相萃取-超声波联合分离提纯藻蓝蛋白的方法
BR112017021016A2 (pt) preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
Curtain The action of urea on the urinary inhibitor of influenza virus haemagglutination.
JPWO2015050191A1 (ja) 二重鎖リボ核酸の精製方法
BR112022026637A2 (pt) Composição, uso de um sistema solvente para preparar um concentrado emulsionável, métodos de preparação de uma composição e de tratamento de solo e plantas, composição de emulsão, processo para preparar uma composição de emulsão, e, uso da composição de emulsão
CN104164422B (zh) 一种从阿胶中提取dna的方法
London A new role for lipid domains?

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 62/892,041 DE 27/08/2019 REIVINDICADA NO PCT/CN2020/111449, CONFORME DETERMINADO NO ART 28 2O, POR NAO CUMPRIMENTO DAS EXIGENCIAS PUBLICADAS NAS RPIS 2682 DE 31/05/2011 E 2692 DE 09/08/2022 PARA APRESENTACAO DA TRADUCAO DA FOLHA DE ROSTO OU DECLARACAO COM OS DADOS IDENTIFICADORES DA PRIORIDADE. NA PETICAO NO 870220017183 DE 25/02/2022 NAO FOI APRESENTADO NENHUM DOCUMENTO REFERENTE A TITULARIDADE DA PRIORIDADE, NA PETICAO NO 870220062742 DE 15/07/2022, EM RESPOSTA A PRIMEIRA EXIGENCIA, FOI APRESENTADA TRADUCAO DA FOLHA REFERENTE AO CERTIFICADO DE DISPONIBILIDADE DE UM DOCUMENTO DE PATENTE EM UMA BIBLIOTECA DIGITAL QUE, ALEM DE NAO CONTER TODOS OS DADOS REQUERIDOS PELO

B12F Other appeals [chapter 12.6 patent gazette]

Free format text: RECURSO: 870220122666 - 27/12/2022